Wall Street Experts
ver. ZuMIgo(08/25)
Inovio Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -112
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
8 |
5 |
4 |
0 |
0 |
1 |
5 |
3 |
5 |
2 |
9 |
6 |
10 |
4 |
13 |
10 |
41 |
35 |
42 |
30 |
4 |
7 |
2 |
10 |
1 |
0 |
Przychód Δ r/r |
0.0% |
-38.8% |
-12.3% |
-95.7% |
-57.5% |
1349.3% |
368.4% |
-36.6% |
38.6% |
-56.4% |
334.8% |
-32.6% |
59.4% |
-58.0% |
227.0% |
-22.4% |
288.0% |
-12.8% |
19.4% |
-27.8% |
-86.5% |
80.2% |
-76.1% |
478.2% |
-91.9% |
-73.8% |
Marża brutto |
85.5% |
71.3% |
56.8% |
100.0% |
100.0% |
100.0% |
96.2% |
93.5% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
-2040.5% |
-1171.7% |
-166.6% |
46.4% |
-321.1% |
100.0% |
EBIT (mln) |
-7 |
-10 |
-6 |
-6 |
-7 |
-12 |
-16 |
-13 |
-16 |
-14 |
-14 |
-19 |
-22 |
-23 |
-20 |
-39 |
-34 |
-76 |
-84 |
-94 |
-111 |
-124 |
-301 |
-268 |
-135 |
-112 |
EBIT Δ r/r |
0.0% |
38.2% |
-41.5% |
6.4% |
11.8% |
73.5% |
34.7% |
-13.9% |
19.1% |
-14.1% |
2.2% |
37.7% |
12.6% |
8.6% |
-16.8% |
102.1% |
-13.2% |
122.4% |
9.7% |
12.5% |
18.1% |
11.7% |
142.8% |
-11.2% |
-49.5% |
-16.9% |
EBIT (%) |
-83.1% |
-187.8% |
-125.2% |
-3131.5% |
-8237.1% |
-986.3% |
-283.6% |
-384.8% |
-330.7% |
-651.1% |
-153.0% |
-312.8% |
-220.9% |
-570.4% |
-145.1% |
-377.7% |
-84.5% |
-215.5% |
-198.1% |
-308.7% |
-2702.1% |
-1674.2% |
-16972.3% |
-2607.4% |
-16253.0% |
-51616.9% |
Koszty finansowe (mln) |
-0 |
0 |
-0 |
0 |
0 |
0 |
3 |
0 |
-3 |
-0 |
11 |
-2 |
0 |
-5 |
88 |
-3 |
-5 |
-2 |
5 |
0 |
8 |
9 |
2 |
1 |
1 |
0 |
EBITDA (mln) |
-7 |
-8 |
-6 |
-5 |
-6 |
-11 |
-8 |
-12 |
-18 |
-13 |
-11 |
-20 |
-29 |
-26 |
24 |
-38 |
-35 |
-75 |
-83 |
-89 |
-106 |
-76 |
-293 |
-269 |
-132 |
-104 |
EBITDA(%) |
-81.9% |
-164.9% |
-125.2% |
-2787.7% |
-7511.4% |
-937.2% |
-147.2% |
-358.5% |
-382.0% |
-606.1% |
-120.9% |
-318.8% |
-301.1% |
-626.0% |
179.6% |
-366.0% |
-85.1% |
-212.8% |
-196.5% |
-293.5% |
-2567.7% |
-1027.8% |
-16528.1% |
-2616.9% |
-15831.9% |
-47735.2% |
Podatek (mln) |
-1 |
1 |
0 |
0 |
-2 |
-1 |
6 |
-1 |
-8 |
-1 |
12 |
-4 |
-16 |
-8 |
88 |
-4 |
-2 |
-5 |
2 |
2 |
-0 |
52 |
2 |
10 |
0 |
0 |
Zysk Netto (mln) |
-7 |
-10 |
-9 |
-6 |
-5 |
-11 |
-15 |
-12 |
-11 |
-13 |
-24 |
-18 |
-15 |
-20 |
-66 |
-36 |
-29 |
-74 |
-88 |
-97 |
-121 |
-215 |
-305 |
-288 |
-135 |
-107 |
Zysk netto Δ r/r |
0.0% |
45.5% |
-7.6% |
-32.7% |
-21.8% |
135.2% |
39.4% |
-18.4% |
-10.2% |
15.7% |
88.3% |
-27.8% |
-13.4% |
29.0% |
235.7% |
-45.3% |
-19.2% |
152.6% |
19.6% |
9.9% |
24.3% |
78.4% |
42.0% |
-5.8% |
-53.0% |
-20.6% |
Zysk netto (%) |
-79.5% |
-189.1% |
-199.1% |
-3147.3% |
-5792.8% |
-940.2% |
-279.8% |
-359.8% |
-233.1% |
-618.1% |
-267.7% |
-286.6% |
-155.7% |
-477.6% |
-490.3% |
-345.4% |
-71.9% |
-208.5% |
-208.9% |
-318.1% |
-2931.8% |
-2902.2% |
-17207.1% |
-2803.1% |
-16239.9% |
-49254.3% |
EPS |
-5.21 |
-6.8 |
-5.13 |
-2.35 |
-1.4 |
-2.49 |
-3.22 |
-1.58 |
-1.08 |
-1.18 |
-1.31 |
-0.68 |
-0.48 |
-0.58 |
-1.43 |
-0.61 |
-0.43 |
-1.01 |
-1.08 |
-1.05 |
-14.65 |
-16.64 |
-17.55 |
-14.47 |
-6.09 |
-3.95 |
EPS (rozwodnione) |
-5.21 |
-6.8 |
-5.13 |
-2.35 |
-1.4 |
-2.49 |
-3.22 |
-1.58 |
-1.08 |
-1.18 |
-1.31 |
-0.68 |
-0.48 |
-0.58 |
-1.43 |
-0.61 |
-0.43 |
-1.01 |
-1.08 |
-1.05 |
-14.65 |
-16.64 |
-17.55 |
-14.47 |
-6.09 |
-3.95 |
Ilośc akcji (mln) |
1 |
1 |
2 |
3 |
3 |
4 |
5 |
8 |
10 |
11 |
19 |
26 |
32 |
34 |
46 |
59 |
68 |
73 |
82 |
92 |
8 |
13 |
17 |
20 |
22 |
27 |
Ważona ilośc akcji (mln) |
1 |
1 |
2 |
3 |
3 |
4 |
5 |
8 |
10 |
11 |
19 |
26 |
32 |
34 |
46 |
59 |
68 |
73 |
82 |
93 |
8 |
13 |
17 |
20 |
22 |
27 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |